Skip to content

News

Vynfinit gains European approval for treatment of platinum-...

Vynfinit gains European approval for treatment of platinum-resistant ovarian cancer

Last week, the European Medicines Agency’s Committee for Medicinal Products for Human Use, or CHMP – the equivalent to the FDA in the United States, recommended approval for vynfinit in the treatment of some platinum resistant ovarian cancers. Vynfinit, developed by Endocyte, targets ovarian cancer cells that have abnormally high levels of the folate receptor. … Continued

Supreme Court to Hear Arguments March 25 on Birth Control C...

Supreme Court to Hear Arguments March 25 on Birth Control Coverage

On March 25 the Supreme Court will hear arguments in two lawsuits that challenge whether for-profit employers must provide health insurance that covers birth control. The lawsuits involve a provision of the Affordable Care Act that requires insurance plans to cover preventive health services, including contraceptives. A number of companies challenged the law, arguing that … Continued

Press Release: Cancer Advocates Debunk Huckabee’s Misleadin...

Press Release: Cancer Advocates Debunk Huckabee’s Misleading Comments on Oral Contraceptives

FOR IMMEDIATE RELEASE: January 24, 2014 Washington, DC—In response to a recent speech by Mike Huckabee, in which he stated that women use oral contraceptives because they “cannot control their libidos or their reproductive systems,” the Ovarian Cancer National Alliance issued the following statement from CEO Calaneet Balas: “In his quest for a quotable sound … Continued

Supreme Court to Consider Two Birth Control Lawsuits

Supreme Court to Consider Two Birth Control Lawsuits

The Supreme Court recently announced that it will hear two cases involving insurance coverage for birth control. The Alliance weighed in on one of these cases, arguing that oral contraceptives are a proven way to prevent ovarian cancer and should therefore be made available to women who wish to reduce their risk. Our CEO Calaneet … Continued

New Cancer Insurance Checklist Helps Patients Choose a Heal...

New Cancer Insurance Checklist Helps Patients Choose a Health Insurance Plan

Many Americans will begin shopping for health insurance on October 1 through the new insurance marketplaces. As a cancer patient, you have unique health care needs that you may want to consider. The Ovarian Cancer National Alliance has partnered with 18 patient advocacy organizations to launch a new tool that will help you pick the … Continued

Report from ASCO 2013–What's New in Ovarian Canc...

Report from ASCO 2013–What's New in Ovarian Cancer Research

We recently returned from the annual meeting of the American Society of Clinical Oncology (ASCO), an annual event that gathers thousands of cancer researchers from around the world. Many new studies on or related to ovarian cancer were presented at this year’s ASCO meeting. Click here to read a summary of ovarian cancer research from … Continued

June 2013 SNMMI Meeting

June 2013 SNMMI Meeting

Society for Nuclear Medicine and Molecular Imaging (SNMMI) Advocate Report from Laurel Pracht As a member of the SNMMI Advocate Advisory Board, formed in 2010 to better bridge the gap between the patient and nuclear medicine communities, I represent the ovarian patient community. Other diseases, including cancer, brain and heart disease are represented as well.  … Continued

Press Release: Ovarian Cancer Advocates Praise Supreme Cour...

Press Release: Ovarian Cancer Advocates Praise Supreme Court Decision on Gene Patents

Ruling Will Give Women More Options to Learn About Genetic Risk Washington, DC—The Supreme Court ruled today that a company cannot patent naturally occurring genes, including isolated gene segments, overturning a decision made by the United States Court of Appeals for the Federal Circuit in August 2012, which upheld a patent claim on the BRCA1 … Continued

New Meta-Analysis of Oral Contraception and Risk of Ovarian...

New Meta-Analysis of Oral Contraception and Risk of Ovarian Cancer

A new meta-analysis of more than 6000 studies shows that oral contraceptives significantly reduce the risk of ovarian cancer. The risk reduction increases proportionally with duration of use. See the abstract here

Experts Tackle Key Issues for Ovarian Cancer in New White P...

Experts Tackle Key Issues for Ovarian Cancer in New White Paper

Last fall, the Alliance convened a ground-breaking meeting in Washington, DC, to consider some of the most challenging topics facing the ovarian cancer community. A group of researchers, oncologists, regulatory experts, advocates and industry representatives attempted to answer questions such as: “How can more women be treated where they live?” “How can we facilitate increased … Continued

Report from the American Association of Cancer Researchers ...

Report from the American Association of Cancer Researchers Meeting

Ovarian cancer survivor Susan Leighton reports on her experience at the American Association of Cancer Researchers meeting, which took place in April 2013. For the second year in a row I had the privilege of being selected to attend the Scientist-Survivor Program (SSP) of the American Association of Cancer Researchers. The SSP program was established … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.